Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Zeo ScientifiX's EPS for the twelve months ending Apr 30, 2026 was -$0.58. For fiscal 2025 it was -$0.86. The highest annual figure on record is $0.00 in fiscal 2014.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$0.86 | – |
| FY2024 | Oct 31, 2024 | -$0.74 | – |
| FY2023 | Oct 31, 2023 | -$0.99 | – |
| FY2022 | Oct 31, 2022 | -$1.56 | – |
| FY2021 | Oct 31, 2021 | -$2.00 | – |
| FY2020 | Oct 31, 2020 | -$4.00 | – |
| FY2019 | Oct 31, 2019 | $0.00 | – |
| FY2018 | Oct 31, 2018 | -$2.00 | – |
| FY2017 | Oct 31, 2017 | -$16.00 | – |
| FY2016 | Oct 31, 2016 | -$2.00 | – |
| FY2015 | Oct 31, 2015 | -$2.00 | – |
| FY2014 | Oct 31, 2014 | $0.00 | – |
| FY2013 | Oct 31, 2013 | -$0.04 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$0.02 | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$0.12 | – |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$0.12 | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | -$0.32 | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | -$0.22 | – |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | -$0.20 | – |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | -$0.23 | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | -$0.17 | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | -$0.16 | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$0.23 | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | -$0.46 | – |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $0.00 | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $0.00 | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | -$0.17 | – |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $0.00 | – |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | -$2.00 | – |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $0.00 | – |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $0.00 | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | -$0.29 | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $0.00 | – |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $0.00 | – |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | -$4.00 | – |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $0.00 | – |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | -$1.67 | – |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | -$2.00 | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | -$6.00 | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | -$8.00 | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $0.00 | – |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | $0.00 | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | $0.00 | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?